{
  "id": "8312b9828d266678",
  "title": "STAT+: Cancer detection firm Freenome to go public via $330 million SPAC deal",
  "description": "Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through blood-based tests, plans to go public.",
  "content": "Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through blood-based tests, plans to go public.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/05/freenome-plans-go-public-early-cancer-detection/?utm_campaign=rss",
  "published_at": "2025-12-05T17:54:05+00:00",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: Cancer detection firm Freenome to go public via $330 million SPAC deal",
    "description": "Freenome, a Bay Area biotech that is part of the increasingly competitive race to accurately detect cancer early through blood-based tests, plans to go public.",
    "url": "https://www.statnews.com/2025/12/05/freenome-plans-go-public-early-cancer-detection/?utm_campaign=rss",
    "published": "2025-12-05T17:54:05+00:00",
    "source": "STAT"
  }
}